A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

A phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving with low-dose semaglutide. HealthDay News — Low-dose semaglutide seems to reduce craving and certain ...

Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

Semaglutide shows promise in reducing alcohol cravings and consumption. Could it be a future treatment for AUD?

Among all antiobesity medications, the largest incremental quality-adjusted life-year (QALY) gains were 0.35 and 0.25 for tirzepatide and semaglutide, respectively, and the corresponding ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo Nordisk's blockbuster diabetes and weight-loss drug Ozempic, Hypera's chief ...

Allurion Technologies' gastric balloon and Novo Nordisk's semaglutide achieved 20.3% weight loss in a trial. Read more here.

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...

Novo Nordisk’s vision of 25%-plus weight loss is looking further and further away. | Novo Nordisk’s vision of 25%-plus weight ...

There is initial evidence that low-dose semaglutide may reduce craving and drinking outcomes in individuals with alcohol-use disorder.